PMA show a specific effect on CLL B-cells, with no effect on other B-cell malignancies, and this effect is enhanced in the presence of IL-4 and T-cell-derived cytokines (21, 22, 195, 196, 239–242, 244, 245). The gene discussed is IL4; the disease is B-cell chronic lymphocytic leukemia.